112 related articles for article (PubMed ID: 1997940)
1. Human colon cancer tissues are more sensitive than rectal cancer tissues to antitumor drugs in vitro.
Ueo H; Maehara Y; Saito A; Sakaguchi Y; Kohnoe S; Sugimachi K
Oncology; 1991; 48(2):158-61. PubMed ID: 1997940
[TBL] [Abstract][Full Text] [Related]
2. Colorectal carcinoma in vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: carboquone, Adriamycin, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil.
Maehara Y; Anai H; Kusumoto H; Kusumoto T; Sugimachi K
Dis Colon Rectum; 1988 Jan; 31(1):62-7. PubMed ID: 3130239
[TBL] [Abstract][Full Text] [Related]
3. [The sensitivity of 1,000 human tumors to antitumor drugs using the succinate dehydrogenase inhibition (SDI) test].
Miyamoto K; Fukuchi K
Rinsho Byori; 1990 Nov; 38(11):1273-8. PubMed ID: 2273570
[TBL] [Abstract][Full Text] [Related]
4. Primary and metastatic liver lesions of clinical colorectal cancer differ in chemosensitivity.
Maehara Y; Sakaguchi Y; Emi Y; Kusumoto T; Kohnoe S; Mori M; Sugimachi K
Int J Colorectal Dis; 1990 May; 5(2):87-9. PubMed ID: 2358741
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Maehara Y; Anai H; Kusumoto H; Sugimachi K
Eur J Surg Oncol; 1987 Jun; 13(3):203-6. PubMed ID: 3036603
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Kanematsu T; Maehara Y; Kusumoto T; Sugimachi K
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1511-3. PubMed ID: 2846313
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity differences between primary and metastatic lesions of clinical gastric cancer.
Kusumoto H; Maehara Y; Kusumoto T; Anai H; Akazawa K; Sugimachi K
Eur J Surg Oncol; 1988 Dec; 14(6):685-9. PubMed ID: 3192005
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitivity testing of human lung cancer tissues using the succinate dehydrogenase inhibition test.
Mitsudomi T; Kaneko S; Tateishi M; Yano T; Ishida T; Kohnoe S; Maehara Y; Sugimachi K
Anticancer Res; 1990; 10(4):987-90. PubMed ID: 2382998
[TBL] [Abstract][Full Text] [Related]
9. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro.
Kohnoe S; Moriguchi S; Emi Y; Sakaguchi Y; Maehara Y; Ishida T; Mitsudomi T; Sugimachi K
Eur J Surg Oncol; 1991 Feb; 17(1):47-50. PubMed ID: 1995357
[TBL] [Abstract][Full Text] [Related]
10. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues.
Takeuchi H; Baba H; Inutsuka S; Takahashi I; Kusumoto H; Maehara Y; Sugimachi K
Anticancer Res; 1994; 14(1A):169-71. PubMed ID: 8166444
[TBL] [Abstract][Full Text] [Related]
11. Tumor tissue is more sensitive to mitomycin C, carboquone, and aclacinomycin A than is adjacent normal tissue in vitro.
Maehara Y; Kusumoto H; Kusumoto T; Anai H; Sugimachi K
J Surg Oncol; 1989 Jan; 40(1):4-7. PubMed ID: 2909804
[TBL] [Abstract][Full Text] [Related]
12. Comparison between succinate dehydrogenase inhibition test and subrenal capsule assay for chemosensitivity testing.
Anai H; Maehara Y; Kusumoto H; Sugimachi K
Oncology; 1987; 44(2):115-7. PubMed ID: 3574851
[TBL] [Abstract][Full Text] [Related]
13. [In vitro chemosensitivity of various human tumors evaluated by the succinate dehydrogenase inhibition (SDI) test (2)].
Anai H; Maehara Y; Kusumoto H; Masuda H; Miyamoto K; Fukuchi K; Tamada R; Sugimachi K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2544-8. PubMed ID: 3740857
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-receptor-negative breast cancer tissue is chemosensitive in vitro compared with estrogen-receptor-positive tissue.
Maehara Y; Emi Y; Sakaguchi Y; Kusumoto T; Kakeji Y; Kohnoe S; Sugimachi K
Eur Surg Res; 1990; 22(1):50-5. PubMed ID: 2379525
[TBL] [Abstract][Full Text] [Related]
15. Resistance to anticancer drugs of well differentiated gastric adenocarcinoma with venous invasion.
Sakaguchi Y; Anai H; Kohnoe S; Emi Y; Kusumoto T; Maehara Y; Sugimachi K
Eur J Surg Oncol; 1992 Apr; 18(2):142-5. PubMed ID: 1582507
[TBL] [Abstract][Full Text] [Related]
16. Human hepatocellular carcinoma sensitivity to antitumor drugs assayed using the succinate dehydrogenase inhibition test.
Kanematsu T; Maehara Y; Matsumata T; Shirabe K; Akazawa K; Sugimachi K
Oncology; 1991; 48(1):34-8. PubMed ID: 1846232
[TBL] [Abstract][Full Text] [Related]
17. Succinate dehydrogenase inhibition test for evaluating head and neck tumors.
Nakashima T; Uemura T; Maehara Y; Sugimachi K
Oncology; 1989; 46(3):162-8. PubMed ID: 2717126
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests].
Saeki T; Jinushi K; Kim R; Kirihara Y; Takagami S; Nishiyama M; Saeki K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1989 May; 16(5):2025-30. PubMed ID: 2730092
[TBL] [Abstract][Full Text] [Related]
19. Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carboquone.
Kusumoto T; Maehara Y; Sakaguchi Y; Kohnoe S; Emi Y; Sugimachi K
Eur J Surg Oncol; 1991 Aug; 17(4):358-63. PubMed ID: 1908390
[TBL] [Abstract][Full Text] [Related]
20. [Study of in vitro cancer sensitivity of anticancer drugs by SDI (succinate dehydrogenase inhibition test)].
Kikuchi Y
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2757-62. PubMed ID: 7993111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
